Financial Summary (All financials)
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 1.5 | 0.6 | 0.1 | 0.0 | 0.0 |
| Research and development | 0.5 | 0.7 | 0.0 | | |
| General and administrative | | | 0.0 | | |
| EBIT | -3.8 | 0.0 | -0.1 | 0.0 | 0.0 |
| Pre-tax income | -3.4 | -1.4 | -0.1 | -0.2 | -0.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -3.4 | -1.4 | -0.1 | 0.0 | 0.0 |
| |
| Diluted EPS | ($0.04) | ($0.02) | ($0.01) | $0.00 | |
| Shares outstanding (diluted) | 84.8 | 71.1 | 13.1 | 0.0 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|